Market News & Trends
Seattle Genetics & Genmab Enter New Antibody-Drug Conjugate Collaboration
Seattle Genetics, Inc. and Genmab A/S recently announced the companies have entered into an additional antibody-drug conjugate (ADC) collaboration. Under the new agreement, Genmab will…
Aerie Announces $125-Million Commitment
Aerie Pharmaceuticals, Inc. recently announced it has received a $125-million financing commitment from Deerfield Management Company L.P., a current Aerie shareholder. The financing is expected…
Premier Group Announces Purity Testing; Develops World’s First 100% Pure Plastic Polymers
Fairfield, NJ - The majority of plastics packaging products require additives to obtain the necessary processing characteristics of physical properties. These additives, technically known as…
Global Markets for Bioengineered Protein Drugs to Reach $222.7 Billion by 2019
The bioengineered protein drug market is one of the fastest growing markets in recent years in the overall pharmaceutical/biotechnology markets. These drugs have gained much…
Selvita Licenses Cresset’s Computational Tools for SAR Analysis & Ligand-Based Design
Cresset, innovative provider of computational chemistry software and services, is pleased to announce that Selvita S.A., a drug discovery company located in Krakow, Poland, has…
Non-Small Cell Lung Cancer Treatment Market Value to Exceed $7.9 Billion by 2020
The global Non-Small Cell Lung Cancer (NSCLC) treatment market value will increase from $5.1 billion in 2013 to slightly over $7.9 billion by 2020, expanding…
Targeted Biologics to Boost Asthma Treatment Market Value to $23.1 Billion
The asthma treatment market value will grow from approximately $15.9 billion in 2013 across eight major countries (the US, UK, France, Germany, Spain, Italy, Japan,…
Pfanstiehl Gearing Up for Potent API Expansion
Pfanstiehl is now making public what many industry experts have suspected was the case ever since the entrepreneurial contract development and manufacturing organization (CDMO) shed…
DPT Laboratories Acquires Meda Pharmaceuticals’ New Jersey Location
DPT Laboratories, a contract development and manufacturing organization (CDMO) with a specialized focus on semi-solid and liquid dosage forms, recently announced the acquisition of Meda…
Catalent Supports Lilly’s Clinical Trials Needs, Makes Major Invetsment
Catalent recently announced that it is to install new automated prefilled syringe clinical packaging lines at its Philadelphia Clinical Supply Center of Excellence, in support…
Ascendia Advances, Successfully Applies Nano-Emulsion Technology Platform
Ascendia Pharmaceuticals, a start-up specialty pharmaceutical company in the business of providing formulation technologies and product development services for poorly soluble molecules, recently announced the…
Targeted Biologics to Boost Asthma Treatment Market Value to $23.1 Billion
The asthma treatment market value will grow from approximately $15.9 billion in 2013 across eight major countries (the US, UK, France, Germany, Spain, Italy, Japan,…
A Changing Market Demands New Approaches to Drug Development
THE POINT OF DEPARTURE Due to a variety of factors, including shrinking product pipelines of many pharma companies, increasing costs associated with drug development, a…
TxCell Granted Five New Patents in Major Global Territories
TxCell SA, a biotech developing innovative, personalized cell-based immunotherapies using antigen-specific regulatory T-cells (Ag-Tregs) for chronic inflammatory and autoimmune diseases, recently announced that five new…
MRC Technology Negotiates License With Bio-Techne
MRC Technology recently announced it has negotiated a license for a protein synthesis technology, Genetically encoded Orthogonal Protection and Activated Ligation (GOPAL), with Bio-Techne, (Techne…
Concert Pharmaceuticals Achieves $2-Million Milestone
Concert Pharmaceuticals, Inc. recently announced that it has achieved a $2- million milestone under its development and license agreement with Avanir Pharmaceuticals, Inc. for the…
EMD Millipore Announces Strategic Alliance on Biopharmaceutical Manufacturing
EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, recently announced that EMD Millipore and Samsung BioLogics have signed an MOU (Memorandum…
Catalent & Minomic to Collaborate on New Cancer Treatment
Catalent recently announced that it is collaborating with privately held Australian biomarker research company, Minomic International Limited, to develop MIL-38, an antibody drug conjugate (ADC)…
US-Manufactured API Urea From FDA-Registered Facility Available Q4 2014
Bangor, PA – BioSpectra announces its cGMP, US-manufactured ICH Q7-based Urea, intended for use as an active pharmaceutical ingredient (API), will be produced in its…
Capsugel & Cardax to Collaborate on Development of Proprietary Products
Capsugel & Cardax to Collaborate on Development of Proprietary Products Capsugel and Cardax, Inc. recently announced a collaboration to develop unique astaxanthin products for the…
